Chiappini Elena, Principi Nicola, Longhi Riccardo, Tovo Pier-Angelo, Becherucci Paolo, Bonsignori Francesca, Esposito Susanna, Festini Filippo, Galli Luisa, Lucchesi Bice, Mugelli Alessandro, de Martino Maurizio
Department of Pediatrics, University of Florence, I-50139 Florence, Italy.
Clin Ther. 2009 Aug;31(8):1826-43. doi: 10.1016/j.clinthera.2009.08.006.
This article summarizes the Italian Pediatric Society guideline on the management of the signs and symptoms of fever in children, prepared as part of the National Guideline Program (NGLP).
Relevant publications in English and Italian were identified through searches of MEDLINE and the Cochrane Database of Systematic Reviews from their inception through December 31, 2007. Based on the consensus of a multidisciplinary expert panel, the strength of the recommendations was categorized into 5 grades (A-E) according to NGLP methodology.
In the health care setting, axillary measurement of body temperature using a digital thermometer is recommended in children aged <4 weeks; for children aged > or =4 weeks, axillary measurement using a digital thermometer or tympanic measurement using an infrared thermometer is recommended. When body temperature is measured at home by parents or care-givers, axillary measurement using a digital thermometer is recommended for all children. Children who are afebrile when seen by the clinician but are reported to have had fever by their caregivers should be considered febrile. In special circumstances, high fever may be a predictive factor for severe bacterial infection. Use of physical methods of reducing fever is discouraged, except in the case of hyperthermia. Use of antipyretics-paracetamol (acetaminophen) or ibuprofen-is recommended only when fever is associated with discomfort. Combined or alternating use of antipyretics is discouraged. The dose of antipyretic should be based on the child's weight rather than age. Whenever possible, oral administration of paracetamol is preferable to rectal administration. Use of ibuprofen is not recommended in febrile children with chickenpox or dehydration. Use of ibuprofen or paracetamol is not contraindicated in febrile children with asthma. There is insufficient evidence to form any recommendations concerning fever in children with other chronic conditions, but caution is advised in cases of severe hepatic/renal failure or severe malnutrition. Newborns with fever should always be hospitalized because of the elevated risk of severe disease; paracetamol may be used, with the dose adjusted to gestational age. Use of paracetamol or ibuprofen is not effective in preventing febrile convulsion or the adverse effects of vaccines.
本文总结了作为国家指南计划(NGLP)一部分所制定的意大利儿科学会关于儿童发热体征和症状管理的指南。
通过检索MEDLINE和Cochrane系统评价数据库,从建库至2007年12月31日,识别出英文和意大利文的相关出版物。基于多学科专家小组的共识,根据NGLP方法,将推荐强度分为5个等级(A - E)。
在医疗环境中,建议对年龄小于4周的儿童使用数字体温计进行腋温测量;对于年龄大于或等于4周的儿童,建议使用数字体温计进行腋温测量或使用红外体温计进行鼓膜温度测量。当家长或护理人员在家中测量体温时,建议对所有儿童使用数字体温计进行腋温测量。临床医生检查时无发热但家长或护理人员报告曾有发热的儿童应被视为发热。在特殊情况下,高热可能是严重细菌感染的预测因素。不鼓励使用物理方法退热,高热情况除外。仅在发热伴有不适时推荐使用退烧药——对乙酰氨基酚(扑热息痛)或布洛芬。不鼓励联合或交替使用退烧药。退烧药的剂量应基于儿童体重而非年龄。尽可能优先口服对乙酰氨基酚而非直肠给药。不建议对患有水痘或脱水的发热儿童使用布洛芬。对患有哮喘的发热儿童使用布洛芬或对乙酰氨基酚无禁忌。对于患有其他慢性病的儿童,尚无足够证据形成任何关于发热的推荐,但对于严重肝/肾衰竭或严重营养不良的情况,建议谨慎处理。发热的新生儿应始终住院,因为患严重疾病的风险较高;可使用对乙酰氨基酚,剂量根据胎龄调整。使用对乙酰氨基酚或布洛芬对预防热性惊厥或疫苗不良反应无效。